Szabó T - Search Results

1

[Experience with surgical treatment of prosthetic valve endocarditis].

Szabolcs Z, Bartha E, Gellér L, Hartyánszky I Jr, Minorics C, Moravcsik E, Hüttl T, Szabó T, Bodor E. Szabolcs Z, et al. Among authors: szabo t. Orv Hetil. 2001 Sep 2;142(35):1907-14. Orv Hetil. 2001. PMID: 11601178 Hungarian.

2

[Atrial fibrillation after open-heart surgery--incidence, prevention and treatment].

Vágó H, Merkely B, Szabolcs Z, Moravcsik E, Gellér L, Szabó T, Turbók E, Matkó I, Bodor E. Vágó H, et al. Among authors: szabo t. Orv Hetil. 2000 Oct 8;141(41):2241-4. Orv Hetil. 2000. PMID: 11184248 Hungarian.

3

Investigating the dual nature of endothelin-1: ischemia or direct arrhythmogenic effect?

Szabó T, Gellér L, Merkely B, Selmeci L, Juhász-Nagy A, Solti F. Szabó T, et al. Life Sci. 2000 May 19;66(26):2527-41. doi: 10.1016/s0024-3205(00)00587-7. Life Sci. 2000. PMID: 10883731

4

[Significance of arterial stiffness parameters for predicting cardiovascular mortality in hemodialysis patients: a prospective cohort study].

El Hadj Othmane T, Kiss I, Nemcsik J, Fekete CB, Deák G, Egresits J, Fodor E, Németh KZ, Szabó T, Szathmári M, Tislér A. El Hadj Othmane T, et al. Among authors: szabo t. Orv Hetil. 2010 May 2;151(18):741-8. doi: 10.1556/OH.2010.28861. Orv Hetil. 2010. PMID: 20410001 Hungarian.

5

Thermographic evaluation of myocardial protection.

Szabó T, Horkay F, Fazekas L, Gellér L, Gyöngy T, Juhász-Nagy A. Szabó T, et al. IEEE Eng Med Biol Mag. 2000 May-Jun;19(3):83-6. doi: 10.1109/51.844385. IEEE Eng Med Biol Mag. 2000. PMID: 10834121 Clinical Trial. No abstract available.

6

Fundamental electrophysiological differences between low-dose intracoronary endothelin-1 infusion and myocardial ischemia revealed by multiple monophasic action potential recording.

Gellér L, Szabó T, Kiss O, Solti F, Juhász-Nagy A, Merkely B. Gellér L, et al. Among authors: szabo t. J Cardiovasc Pharmacol. 2000 Nov;36(5 Suppl 1):S167-71. doi: 10.1097/00005344-200036051-00052. J Cardiovasc Pharmacol. 2000. PMID: 11078368

7

Increased monophasic action potential dispersion in endothelin-1-induced ventricular arrhythmias.

Gellér L, Merkely B, Lang V, Szabó T, Fazekas L, Kékesi V, Kiss O, Horkay F, Schaldach M, Tóth M, Juhász-Nagy A. Gellér L, et al. Among authors: szabo t. J Cardiovasc Pharmacol. 1998;31 Suppl 1:S434-6. doi: 10.1097/00005344-199800001-00124. J Cardiovasc Pharmacol. 1998. PMID: 9595505

8

[Osteoprotegerin: regulator, protector and marker].

El Hadj Othmane T, Speer G, Fekete B, Szabó T, Egresits J, Fodor E, Kiss I, Nemcsik J, Szabó A, Németh Z, Szathmári M, Tislér A. El Hadj Othmane T, et al. Among authors: szabo a, szabo t. Orv Hetil. 2008 Oct 19;149(42):1971-80. doi: 10.1556/OH.2008.28470. Orv Hetil. 2008. PMID: 18842549 Review. Hungarian.

9

The selective endothelin-A-receptor antagonist LU 135.252 inhibits the direct arrhythmogenic action of endothelin-1.

Merkely B, Szabó T, Gellér L, Kiss O, Horkay F, Raschack M, Juhász-Nagy A. Merkely B, et al. Among authors: szabo t. J Cardiovasc Pharmacol. 2000 Nov;36(5 Suppl 1):S314-6. doi: 10.1097/00005344-200036051-00091. J Cardiovasc Pharmacol. 2000. PMID: 11078407

10

Endothelin-A-receptor antagonist LU 135.252 inhibits the formation of ventricular arrhythmias caused by intrapericardial infusion of endothelin-1.

Kiss O, Gellér L, Merkely B, Szabó T, Raschack M, Seres L, Zima E, Juhász-Nagy A, Horkay F. Kiss O, et al. Among authors: szabo t. J Cardiovasc Pharmacol. 2000 Nov;36(5 Suppl 1):S317-9. doi: 10.1097/00005344-200036051-00092. J Cardiovasc Pharmacol. 2000. PMID: 11078408

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

549 results

Search Page

Filters